1,206
Views
125
CrossRef citations to date
0
Altmetric
Review

Drug delivery approaches for breast cancer

, , &
Pages 6205-6218 | Published online: 24 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Elham Moradi, TaranehSadat Zavvar, Mona Alibolandi, Mohammad Ramezani, Khalil Abnous & Seyed Mohammad Taghdisi. (2023) Targeted delivery of epirubicin to breast cancer cells using poly-aptamer DNA nanocarriers prepared by the RCA method with multiple repeats of aptamers of FOXM1 and AS1411. Drug Development and Industrial Pharmacy 49:3, pages 260-270.
Read now
Jitu Halder, Deepak Pradhan, Prativa Biswasroy, Vineet Kumar Rai, Biswakanth Kar, Goutam Ghosh & Goutam Rath. (2022) Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer. Journal of Drug Targeting 30:10, pages 1055-1075.
Read now
Mostafa Zamani, Mozhgan Aghajanzadeh, Ali Sharafi, Kobra Rostamizadeh & Hossein Danafar. (2022) Targeted drug delivery via folate decorated nanocarriers based on linear polymer for treatment of breast cancer. Pharmaceutical Development and Technology 27:1, pages 19-24.
Read now
Samer Hasan Hussein-Al-Ali, Mohd Zobir Hussein, Saifullah Bullo & Palanisamy Arulselvan. (2021) Chlorambucil-Iron Oxide Nanoparticles as a Drug Delivery System for Leukemia Cancer Cells. International Journal of Nanomedicine 16, pages 6205-6216.
Read now
Rahul Mittal, Stefanie A. Pena, Angela Zhu, Nicolas Eshraghi, Arian Fesharaki, Elijah J. Horesh, Jeenu Mittal & Adrien A. Eshraghi. (2019) Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1312-1320.
Read now
Adil M. Allahverdiyev, Etkin Parlar, Sahar Dinparvar, Melahat Bagirova & Emrah Şefik Abamor. (2018) Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 755-762.
Read now

Articles from other publishers (119)

Akanksha Behl & Anil K. Chhillar. (2023) Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer. Recent Patents on Anti-Cancer Drug Discovery 18:3, pages 325-342.
Crossref
Zhongguan Huang, Shuainan Chen, H. Elhosiny Ali, Dalia H. Elkamchouchi, Jun Hu, Elimam Ali, Jie Zhang & Yideng Huang. (2023) Application of CNN and ANN in assessment the effect of chemical components of biological nanomaterials in treatment of infection of inner ear and environmental sustainability. Chemosphere 331, pages 138458.
Crossref
Janske Nel, Kamil Elkhoury, Émilie Velot, Arnaud Bianchi, Samir Acherar, Grégory Francius, Ali Tamayol, Stéphanie Grandemange & Elmira Arab-Tehrany. (2023) Functionalized liposomes for targeted breast cancer drug delivery. Bioactive Materials 24, pages 401-437.
Crossref
Shiza Malik, Maha Niazi, Maham Khan, Bisma Rauff, Sidra Anwar, Faheem Amin & Rumeza Hanif. (2023) Cytotoxicity Study of Gold Nanoparticle Synthesis Using Aloe vera , Honey, and Gymnema sylvestre Leaf Extract . ACS Omega 8:7, pages 6325-6336.
Crossref
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies & Rajesh Singh. (2023) Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers 15:4, pages 1320.
Crossref
Liliana-Roxana Balahura (Stămat), Sorina Dinescu & Marieta Costache. (2023) Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy. International Journal of Molecular Sciences 24:4, pages 3245.
Crossref
Vivek P. Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K. Singla, Avinash Khadela, Lalitkumar Vora & Vladimir N. Uversky. (2023) Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15:4, pages 1023.
Crossref
Mostafa G.M. El-Gazzar, Mostafa M. Ghorab, Mohamed A. Amin, Mohamed Korany, Mohammed A. Khedr, Marwa G. El-Gazzar & Tamer M. sakr. (2023) Computational, in vitro and radiation-based in vivo studies on acetamide quinazolinone derivatives as new proposed purine nucleoside phosphorylase inhibitors for breast cancer. European Journal of Medicinal Chemistry 248, pages 115087.
Crossref
Xuanping Zhao, Chuan Liu, Zichao Wang, Yingyuan Zhao, Xuyang Chen, Haizhen Tao, Hong Chen, Xueqin Wang & Shaofeng Duan. (2023) Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells. Pharmaceutics 15:1, pages 276.
Crossref
Qiang Chen, Xiaoyu Huang, Geyi Zhang, Jiangnan Li, Yang Liu & Xu Yan. (2023) Novel targeted pH-responsive drug delivery systems based on PEGMA-modified bimetallic Prussian blue analogs for breast cancer chemotherapy. RSC Advances 13:3, pages 1684-1700.
Crossref
Marziyeh Fathi, Shaghayegh Aslzad, Jaleh Barar & Yadollah Omidi. 2023. Advanced Nanoformulations. Advanced Nanoformulations 719 744 .
Nazan GÖKŞEN TOSUN, Özlem KAPLAN, Seçil ERDEN TAYHAN, Cemil ALKAN & İsa GÖKÇE. (2022) A new approach to breast cancer therapy: targeted nanocarrier systemsMeme kanseri tedavisinde yeni bir yaklaşım: hedefledirilmiş nanotaşıyıcı sistemler. International Journal of Chemistry and Technology 6:2, pages 81-92.
Crossref
Binnaz KIRBIYIK, Birgül MAZMANCI, Şeyma Gülnaz YARLILAR, Naz UĞUR & Kasım OCAKOĞLU. (2022) Tamoxifen Delivery to Breast Cancer Cells (MCF-7) Via Hydroxyapatite Microspheres. Eurasian Journal of Biological and Chemical Sciences 5:(Ek sayı 1), pages 111-118.
Crossref
Poonam Banthia, Lokesh Gambhir, Dhiraj Daga, Asha Sharma, Neha Kapoor, R. D. Agarwal & Gaurav Sharma. (2022) Phytogenic synthesis of metallic nanoparticles: application for breast cancer nanomedicine. Vegetos 36:1, pages 10-19.
Crossref
Urmila Kafle, Satish Agrawal & Alekha K. Dash. (2022) Injectable Nano Drug Delivery Systems for the Treatment of Breast Cancer. Pharmaceutics 14:12, pages 2783.
Crossref
Mahak Fatima, Afsana Sheikh, Mohammed A. S. Abourehab & Prashant Kesharwani. (2022) Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer. Pharmaceutics 14:11, pages 2432.
Crossref
Yinxi Yang, Yifeng Wu, Lihong Hou, Xin Ge, Guoquan Song & Hongdou Jin. (2022) Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways. Oncology Letters 24:6.
Crossref
Vaishnavi Gadi, Dhruv Gupta & Saritha Shetty. (2022) Emerging potentials of nanotherapeutics in breast cancer microenvironment targeting. OpenNano 8, pages 100101.
Crossref
Salsa Lina AgustinTri WidiandaniSuko HardjonoBambang Tri Purwanto. (2022) QSAR of Acyl pinostrobin derivatives as Anti-breast cancer against HER-2 receptor and their ADMET properties based on in silico Study. Research Journal of Pharmacy and Technology, pages 4641-4648.
Crossref
Xiaoshi Li. (2022) LINC01140 Targeting miR-452-5p/RGS2 Pathway to Attenuate Breast Cancer Tumorigenesis. Disease Markers 2022, pages 1-12.
Crossref
Manisha Pandey, Pung Xiau Wen, Giam Mun Ning, Gan Jia Xing, Liu Man Wei, Dinesh Kumar, Jayashree Mayuren, Mayuren Candasamy, Bapi Gorain, Neha Jain, Gaurav Gupta & Kamal Dua. (2022) Intraductal delivery of nanocarriers for ductal carcinoma in situ treatment: a strategy to enhance localized delivery . Nanomedicine 17:24, pages 1871-1889.
Crossref
Sedighe Forouhari, Zahra Beygi, Zahra Mansoori, Sara Hajsharifi, Fatemeh Heshmatnia & Seyed Mohammad Gheibihayat. (2021) Liposomes: Ideal drug delivery systems in breast cancer. Biotechnology and Applied Biochemistry 69:5, pages 1867-1884.
Crossref
Luminita Claudia Miclea, Mona Mihailescu, Nicolae Tarba, Ana-Maria Brezoiu, Ana Maria Sandu, Raul-Augustin Mitran, Daniela Berger, Cristian Matei, Mihaela Georgeta Moisescu & Tudor Savopol. (2022) Evaluation of intracellular distribution of folate functionalized silica nanoparticles using fluorescence and hyperspectral enhanced dark field microscopy. Nanoscale 14:35, pages 12744-12756.
Crossref
Popat Kumbhar, Kapil Kole, Varsha Khadake, Pradnya Marale, Arehalli Manjappa, Sameer Nadaf, Rajendra Jadhav, Ajit Patil, Sachin Kumar Singh, Kamal Dua, Niraj Kumar Jha, John Disouza & Vandana Patravale. (2022) Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer. Journal of Controlled Release 349, pages 812-830.
Crossref
Shivaprasad Gadag, Reema Narayan, Jayalakshmi N. Sabhahit, Gangadhar Hari, Yogendra Nayak, Karkala Sreedhara Ranganath Pai, Sanjay Garg & Usha Y. Nayak. (2022) Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer. Biomaterials Advances 140, pages 213085.
Crossref
Insha Nahvi, Sana Belkahla, Supratim Biswas & Suparna Chakraborty. (2022) A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario. Frontiers in Oncology 12.
Crossref
Rishabh Verma, Preeti Vyas, Jasmeet Kaur, Md. Noushad Javed, Mohammad Sarafroz, Makhmur Ahmad, Sadaf Jamal Gilani & Mohamad Taleuzzaman. (2022) Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases. CNS & Neurological Disorders - Drug Targets 21:6, pages 479-491.
Crossref
Kalyani Pathak, Manash P. Pathak, Riya Saikia, Urvashee Gogoi, Jon J. Sahariah, James H. Zothantluanga, Abhishek Samanta & Aparoop Das. (2022) Cancer Chemotherapy via Natural Bioactive Compounds . Current Drug Discovery Technologies 19:4.
Crossref
Abdulsalam Alhalmi, Sarwar Beg, Waleed H. Almalki, Saad Alghamdi & Kanchan Kohli. (2022) Recent Advances in Nanotechnology-Based Targeted Therapeutics for Breast Cancer Management. Current Drug Metabolism 23:8, pages 587-602.
Crossref
Chaochao Yu, Yi Li, Guopeng Chen, Chaoyan Wu, Xiuping Wang & Yingwen Zhang. (2022) Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges动物来源中药活性组分在乳腺癌中的运用: 机遇和挑战. Journal of Zhejiang University-SCIENCE B 23:7, pages 547-563.
Crossref
Francesca Grilli, Parisa Hajimohammadi Gohari & Shan Zou. (2022) Characteristics of Graphene Oxide for Gene Transfection and Controlled Release in Breast Cancer Cells. International Journal of Molecular Sciences 23:12, pages 6802.
Crossref
Mamata Singh, Nishant Kumar Rana, Madaswamy S. Muthu, Abhishek Jha, Tushar S. Basu Baul & Biplob Koch. (2022) Enhanced in vitro therapeutic efficacy of triphenyltin (IV) loaded vitamin E TPGS against breast cancer therapy. Materials Today Communications 31, pages 103256.
Crossref
Wen Nie, Jing Chen, Bilan Wang & Xiang Gao. (2022) Nonviral vector system for cancer immunogene therapy. MedComm – Biomaterials and Applications 1:1.
Crossref
Sumera Zaib, B. S. Areeba, B. S. Nehal Rana, Javed Iqbal Wattoo, Hashem O. Alsaab, Rami M. Alzhrani, Nasser S. Awwad, Hala A. Ibrahium & Imtiaz Khan. (2022) Nanomedicines Targeting Heat Shock Protein 90 Gene Expression in the Therapy of Breast Cancer. ChemistrySelect 7:14.
Crossref
Imran Kazmi, Fahad A. Al-Abbasi, Syed Sarim Imam, Muhammad Afzal, Muhammad Shahid Nadeem, Hisham N. Altayb & Sultan Alshehri. (2022) Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles. Pharmaceutics 14:4, pages 783.
Crossref
Faten Eshrati Yeganeh, Amir Eshrati Yeganeh, Mohammad Yousefi, Bahareh Farasati Far, Iman Akbarzadeh, Dmitry Olegovich Bokov, Kaamran Raahemifar & Madjid Soltani. (2022) Formulation and Characterization of Poly (Ethylene Glycol)-Coated Core-Shell Methionine Magnetic Nanoparticles as a Carrier for Naproxen Delivery: Growth Inhibition of Cancer Cells. Cancers 14:7, pages 1797.
Crossref
Md. Rezaul Islam, Fahadul Islam, Mohamed H. Nafady, Muniya Akter, Saikat Mitra, Rajib Das, Humaira Urmee, Sheikh Shohag, Aklima Akter, Kumarappan Chidambaram, Fahad A. Alhumaydhi, Talha Bin Emran & Simona Cavalu. (2022) Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint. Molecules 27:7, pages 2165.
Crossref
Mariia Kiseleva, Mahmoud M. Omar, Élodie Boisselier, Svetlana V. Selivanova & Marc-André Fortin. (2022) A Three-Dimensional Printable Hydrogel Formulation for the Local Delivery of Therapeutic Nanoparticles to Cervical Cancer. ACS Biomaterials Science & Engineering 8:3, pages 1200-1214.
Crossref
Poonam Banthia, Lokesh Gambhir, Asha Sharma, Dhiraj Daga, Neha Kapoor, Rishabh Chaudhary & Gaurav Sharma. (2022) Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech 12:3.
Crossref
Muhammad Qamar, Ghulam Abbas, Muhammad Afzaal, Muhammad Y. Naz, Abdul Ghuffar, Muhammad Irfan, Stanislaw Legutko, Jerzy Jozwik, Magdalena Zawada-Michalowska, Abdulnour Ali Jazem Ghanim, Saifur Rahman, Usama M. Niazi, Mohammed Jalalah, Fahad Salem Alkahtani, Mohammad K. A. Khan & Ewelina Kosicka. (2022) Gold Nanorods for Doxorubicin Delivery: Numerical Analysis of Electric Field Enhancement, Optical Properties and Drug Loading/Releasing Efficiency. Materials 15:5, pages 1764.
Crossref
Boshu Sun, Liangliang Xu, Wenhui Bi & Wen-Bin Ou. (2022) SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance. International Journal of Molecular Sciences 23:4, pages 2053.
Crossref
Arfa Nasrine, Mohammed Gulzar Ahmed & Soumya Narayana. (2022) Silk fibroin-anastrozole loaded prolonged-release biodegradable nanomedicine: A promising drug delivery system for breast cancer therapy. Materials Today: Proceedings 68, pages 56-65.
Crossref
Akanksha Malaiya, Mansha Singhai, Shivani Rai Paliwal & Rishi Paliwal. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy 27 44 .
Xiao-Ling Xu, Nan-Nan Zhang, Gao-Feng Shu, Di Liu, Jing Qi, Fei-Yang Jin, Jian-Song Ji & Yong-Zhong Du. (2021) A Luminol-Based Self-Illuminating Nanocage as a Reactive Oxygen Species Amplifier to Enhance Deep Tumor Penetration and Synergistic Therapy. ACS Nano 15:12, pages 19394-19408.
Crossref
P. Motamed Fath, M. Rahimnejad, S. Moradi-kalbolandi, B. Ebrahimi Hosseinzadeh & T. Jamshidnejad-tosaramandani. (2022) Improvement of cytotoxicity and necrosis activity of ganoderic acid a through the development of PMBN-A.Her2-GA as a targeted nano system. RSC Advances 12:2, pages 1228-1237.
Crossref
Afsana Sheikh, Shadab Md & Prashant Kesharwani. (2021) RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. Journal of Controlled Release 340, pages 221-242.
Crossref
Xiaoli Hu, Yang Liu, Zhitong Bing, Qian Ye & Chengcheng Li. (2021) High Moesin Expression Is a Predictor of Poor Prognosis of Breast Cancer: Evidence From a Systematic Review With Meta-Analysis. Frontiers in Oncology 11.
Crossref
Melayshia McFadden, Santosh Kumar Singh, Gabriela Oprea-Ilies & Rajesh Singh. (2021) Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers. Cancers 13:21, pages 5480.
Crossref
Syeda Warisul Fatima, Khalid Imtiyaz, Mohammad M. Alam Rizvi & Sunil K. Khare. (2021) Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics. RSC Advances 11:55, pages 34613-34630.
Crossref
Hamidu Ahmed, Mokrish Ajat, Rana I. Mahmood, Rozaihan Mansor, Intan Shameha Abdul Razak, Jameel R. Al-Obaidi, Nurhanani Razali, Alhaji Zubair Jaji, Abubakar Danmaigoro & Md Zuki Abu Bakar. (2021) LC-MS/MS Proteomic Study of MCF-7 Cell Treated with Dox and Dox-Loaded Calcium Carbonate Nanoparticles Revealed Changes in Proteins Related to Glycolysis, Actin Signalling, and Energy Metabolism. Biology 10:9, pages 909.
Crossref
Denis V. Voronin, Anatolii A. Abalymov, Yulia I. Svenskaya & Maria V. Lomova. (2021) Key Points in Remote-Controlled Drug Delivery: From the Carrier Design to Clinical Trials. International Journal of Molecular Sciences 22:17, pages 9149.
Crossref
Wentao Xia, Zixuan Tao, Bin Zhu, Wenxiang Zhang, Chang Liu, Siyu Chen & Mingming Song. (2021) Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy. International Journal of Molecular Sciences 22:17, pages 9118.
Crossref
Rahul Chadar, Afsana & Prashant Kesharwani. (2021) Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer. International Journal of Pharmaceutics 605, pages 120835.
Crossref
Abdolamir Ghadaksaz, Abbas Ali Imani Fooladi, Hamideh Mahmoodzadeh Hosseini, Taher Nejad Satari & Mohsen Amin. (2021) ARA-linker-TGFαL3: a novel chimera protein to target breast cancer cells. Medical Oncology 38:8.
Crossref
Aswathi R Hegde, Ruchira Raychaudhuri, Abhijeet Pandey, Guruprasad Kalthur & Srinivas Mutalik. (2021) Exploring potential formulation strategies for chemoprevention of breast cancer: a localized delivery perspective. Nanomedicine 16:13, pages 1111-1132.
Crossref
Ning Li, Zhenyu Duan, Lili Wang, Chunhua Guo, Hu Zhang, Zhongwei Gu, Qiyong Gong & Kui Luo. (2021) An Amphiphilic PEGylated Peptide Dendron‐Gemcitabine Prodrug‐Based Nanoagent for Cancer Therapy. Macromolecular Rapid Communications 42:12, pages 2100111.
Crossref
Swapnil Mehta, Sanjay Kulkarni, Ajinkya N. Nikam, Bharat S. Padya, Abhijeet Pandey & Srinivas Mutalik. (2021) Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects. Current Pharmaceutical Design 27:17, pages 1977-1991.
Crossref
Wei Ren, Fuchun Nan, Shumu Li, Sijin Yang, Jiechao Ge & Zhenwen Zhao. (2020) Red Emissive Carbon Dots Prepared from Polymers as an Efficient Nanocarrier for Coptisine Delivery in vivo and in vitro. ChemMedChem 16:4, pages 646-653.
Crossref
Rita Moreira, Andreia Granja, Marina Pinheiro & Salette Reis. (2021) Nanomedicine Interventions in Clinical Trials for the Treatment of Metastatic Breast Cancer. Applied Sciences 11:4, pages 1624.
Crossref
Balney Rajitha, Rama Rao Malla, Ramakrishna Vadde, Prameswari Kasa, Ganji Lakshmi Vara Prasad, Batoul Farran, Seema Kumari, Eluri Pavitra, Mohammad Amjad Kamal, Ganji Seeta Rama Raju, Sujatha Peela & Ganji Purnachandra Nagaraju. (2021) Horizons of nanotechnology applications in female specific cancers. Seminars in Cancer Biology 69, pages 376-390.
Crossref
Veena S. Belgamwar, Suchitra S. Mishra, Vidyadevi T. Bhoyar & Kunal B. Banode. 2021. Nanopharmaceutical Advanced Delivery Systems. Nanopharmaceutical Advanced Delivery Systems 333 355 .
Faizah A. AlMalki, Aziza M. Hassan, Zeinab M. Klaab, Soliman Abdulla & Antonio Pizzi. (2021) Tannin Nanoparticles (NP99) Enhances the Anticancer Effect of Tamoxifen on ER+ Breast Cancer Cells. Journal of Renewable Materials 9:12, pages 2077-2092.
Crossref
Rakesh Kumar Sahoo, Sarita Rani, Vinay Kumar & Umesh Gupta. 2021. Nanostructured Zinc Oxide. Nanostructured Zinc Oxide 483 509 .
Humzah Jamshaid & Fakhar-ud-Din. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics 125 159 .
Kamil Kucharczyk, Anna Florczak, Tomasz Deptuch, Karolina Penderecka, Katarzyna Jastrzebska, Andrzej Mackiewicz & Hanna Dams-Kozlowska. (2020) Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells. Journal of Nanobiotechnology 18:1.
Crossref
Liyu QianQiaoman FeiHaoran ZhangManman QiuBo ZhangQin WangYang YuChenxu GuoYu RenMei MeiLing ZhangYu ZhuBing Yang. (2020) lncRNA HOTAIR Promotes DNA Repair and Radioresistance of Breast Cancer via EZH2 . DNA and Cell Biology 39:12, pages 2166-2173.
Crossref
Loveleen Kaur, Harvinder S. Sohal, Manvinder Kaur, Dharambeer S. Malhi & Sonali Garg. (2020) A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 20:17, pages 2012-2024.
Crossref
Daphne Christine Salles de Oliveira, Camila Fabiano de Freitas, Italo Rodrigo Calori, Renato Sonchini Goncalves, Camila Aparecida Errerias Fernandes Cardinali, Luis Carlos Malacarne, Maria Ida Ravanelli, Hueder Paulo Moises de Oliveira, Antonio Claudio Tedesco, Wilker Caetano, Noboru Hioka & André Luiz Tessaro. (2020) Theranostic verteporfin- loaded lipid-polymer liposome for photodynamic applications. Journal of Photochemistry and Photobiology B: Biology 212, pages 112039.
Crossref
Kehinde Aruleba, George Obaido, Blessing Ogbuokiri, Adewale Oluwaseun Fadaka, Ashwil Klein, Tayo Alex Adekiya & Raphael Taiwo Aruleba. (2020) Applications of Computational Methods in Biomedical Breast Cancer Imaging Diagnostics: A Review. Journal of Imaging 6:10, pages 105.
Crossref
Qi-Yao Wei, Yan-Ming Xu & Andy T. Y. Lau. (2020) Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies. Cancers 12:10, pages 2783.
Crossref
Kamila Butowska, Krzysztof Żamojć, Mateusz Kogut, Witold Kozak, Dariusz Wyrzykowski, Wiesław Wiczk, Jacek Czub, Jacek Piosik & Janusz Rak. (2020) The Product of Matrix Metalloproteinase Cleavage of Doxorubicin Conjugate for Anticancer Drug Delivery: Calorimetric, Spectroscopic, and Molecular Dynamics Studies on Peptide–Doxorubicin Binding to DNA. International Journal of Molecular Sciences 21:18, pages 6923.
Crossref
Lushan Wang, Ning Wang, Runshi Zhang, Dong Dong, Rui Liu, Lufang Zhang, Wei Ji, Man Yu, Fei Zhang, Ruifang Niu & Yunli Zhou. (2020) TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells. Life Sciences 256, pages 117674.
Crossref
Santosh Kumar Singh, Jennifer B. Gordetsky, Sejong Bae, Edward P. Acosta, James W. LillardJr.Jr. & Rajesh Singh. (2020) Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer. Cells 9:9, pages 1976.
Crossref
Alberto Juan, Francisco J. Cimas, Iván Bravo, Atanasio Pandiella, Alberto Ocaña & Carlos Alonso-Moreno. (2020) Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment. International Journal of Molecular Sciences 21:17, pages 6018.
Crossref
Min Zhang, Feng Wang, Zhen Xiang, Teng Huang & Wei‐Bing Zhou. (2020) LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR‐200c‐3p to upregulate ANLN. Clinical and Experimental Pharmacology and Physiology 47:8, pages 1464-1472.
Crossref
Seyed Mohammad Taghdisi, Noor Mohammad Danesh, Morteza Alinezhad Nameghi, Amirhossein Bahreyni, Mohammad Ramezani, Mona Alibolandi, Ahmad Sarreshtehdar Emrani & Khalil Abnous. (2020) Co-delivery of doxorubicin and α-PCNA aptamer using AS1411-modified pH-responsive nanoparticles for cancer synergistic therapy. Journal of Drug Delivery Science and Technology 58, pages 101816.
Crossref
Amar Patil, Roma Narvenker, Bala Prabhakar & Pravin Shende. (2020) Strategic consideration for effective chemotherapeutic transportation via transpapillary route in breast cancer. International Journal of Pharmaceutics 586, pages 119563.
Crossref
Nehal M. El-Deeb, Mai A. Abo-Eleneen, Lamiaa A. Al-Madboly, Mona M. Sharaf, Sarah S. Othman, Omar M. Ibrahim & Mohammad S. Mubarak. (2020) Biogenically Synthesized Polysaccharides-Capped Silver Nanoparticles: Immunomodulatory and Antibacterial Potentialities Against Resistant Pseudomonas aeruginosa. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Israel González-Méndez, Rodrigo Aguayo-Ortiz, Kendra Sorroza-Martínez, José D. Solano, Pasquale Porcu, Ernesto Rivera & Laura Dominguez. (2020) Conformational analysis by NMR and molecular dynamics of adamantane-doxorubicin prodrugs and their assemblies with β-cyclodextrin: A focus on the design of platforms for controlled drug delivery. Bioorganic & Medicinal Chemistry 28:13, pages 115510.
Crossref
Sayed Tayyab Raza Naqvi, Tahir Rasheed, Dilshad Hussain, Saadat Majeed, Batool Fatima, Muhammad Najam ul Haq, Ayesha Zarin & Rahat Nawaz. (2020) Development of molecularly imprinted magnetic iron oxide nanoparticles for doxorubicin drug delivery. Monatshefte für Chemie - Chemical Monthly 151:7, pages 1049-1057.
Crossref
Mona Elhabak, Rihab Osman, Mona Mohamed, Ola M. El-Borady, Gehanne A. S. Awad & Nahed Mortada. (2020) Near IR responsive targeted integrated lipid polymer nanoconstruct for enhanced magnolol cytotoxicity in breast cancer. Scientific Reports 10:1.
Crossref
Phuong Tran, Sang-Eun Lee, Dong-Hyun Kim, Yong-Chul Pyo & Jeong-Sook Park. (2019) Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment. Journal of Pharmaceutical Investigation 50:3, pages 261-270.
Crossref
Ranjit K. Harwansh, Shiv Bahadur, Rohitas Deshmukh & Md. A. Rahman. (2020) Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective. Current Pharmaceutical Design 26:11, pages 1191-1205.
Crossref
Matthew A. Moss, Breanne Williams, Farzana Ferdous, Tom Scott & Heather W. Dunn. (2020) Methodology to analyze gene expression patterns of early mammary development in pig models. Molecular Biology Reports 47:4, pages 3241-3248.
Crossref
Roghayyeh Vakili-Ghartavol, Seyed Mahdi Rezayat, Reza Faridi-Majidi, Kayvan Sadri & Mahmoud Reza Jaafari. (2020) Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy. Scientific Reports 10:1.
Crossref
Nanyak Galam, Pinar Tulay & Terin Adali. (2020) In Vitro MCF-7 Cells Apoptosis Analysis of Carboplatin Loaded Silk Fibroin Particles. Molecules 25:5, pages 1110.
Crossref
Omar M. Ibrahim, Nehal M. El-Deeb, Haidy Abbas, Soha M. Elmasry & M.R. El-Aassar. (2020) Alginate based tamoxifen/metal dual core-folate decorated shell: Nanocomposite targeted therapy for breast cancer via ROS-driven NF-κB pathway modulation. International Journal of Biological Macromolecules 146, pages 119-131.
Crossref
Selvaraj Kunjiappan, Theivendren Panneerselvam, Saravanan Govindaraj, Pavadai Parasuraman, Suraj Baskararaj, Murugesan Sankaranarayanan, Sankarganesh Arunachalam, Ewa Babkiewicz, Aarthi Jeyakumar & Muthulakshmi Lakshmanan. (2020) Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment. Anti-Cancer Agents in Medicinal Chemistry 19:16, pages 1966-1982.
Crossref
Na Re Ko, Se Young Van, Sung Hwa Hong, Seog-Young Kim, Miran Kim, Jae Seo Lee, Sang Ju Lee, Yong-kyu Lee, Il Keun Kwon & Seung Jun Oh. (2020) Dual pH- and GSH-Responsive Degradable PEGylated Graphene Quantum Dot-Based Nanoparticles for Enhanced HER2-Positive Breast Cancer Therapy. Nanomaterials 10:1, pages 91.
Crossref
Chong Liu, Fan Yao, Xiaoyun Mao, Wanming Li & Hang Chen. (2020) Effect of SALL4 on the Proliferation, Invasion and Apoptosis of Breast Cancer Cells. Technology in Cancer Research & Treatment 19, pages 153303382098007.
Crossref
David Anwanwan, Santosh Kumar Singh, Shriti Singh, Varma Saikam & Rajesh Singh. (2020) Challenges in liver cancer and possible treatment approaches. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1873:1, pages 188314.
Crossref
Vijay Mishra, Nishika Yadav & Gaurav K. Saraogi. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents 423 449 .
Salma Mirza, Malik Shoaib Ahmad, Muhammad Ishaq Ali Shah & Muhammad Ateeq. 2020. Metal Nanoparticles for Drug Delivery and Diagnostic Applications. Metal Nanoparticles for Drug Delivery and Diagnostic Applications 189 213 .
Manjula Vinayak & Akhilendra K. Maurya. (2019) Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development. Anti-Cancer Agents in Medicinal Chemistry 19:13, pages 1560-1576.
Crossref
Hayrettin Tonbul, Adem Sahin, Ece Tavukcuoglu, Gunes Esendagli & Yılmaz Capan. (2019) Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer. Journal of Drug Delivery Science and Technology 54, pages 101380.
Crossref
Adaugo Q. Ohandjo, Zongzhi Liu, Eric B. Dammer, Courtney D. Dill, Tiara L. Griffen, Kaylin M. Carey, Denise E. Hinton, Robert Meller & James W. LillardJr.Jr.. (2019) Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment. Scientific Reports 9:1.
Crossref
Jiang Pi, Ling Shen, Hongbo Shen, Enzhuo Yang, Wandang Wang, Richard Wang, Dan Huang, Bao-Shiang Lee, Chunmiao Hu, Crystal Chen, Hua Jin, Jiye Cai, Gucheng Zeng & Zheng W. Chen. (2019) Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency. Materials Science and Engineering: C 103, pages 109777.
Crossref
Alireza Hassanpour, Mohsen Irandoust, Ebrahim Soleimani & Hossein Zhaleh. (2019) Increasing the anticancer activity of azidothymidine toward the breast cancer via rational design of magnetic drug carrier based on molecular imprinting technology. Materials Science and Engineering: C 103, pages 109771.
Crossref
Cirillo, Curcio, Nicoletta & Iemma. (2019) Injectable Hydrogels for Cancer Therapy over the Last Decade. Pharmaceutics 11:9, pages 486.
Crossref
Ali Alirezaie Alavijeh, Mohammad Barati, Meisam Barati & Hussein Abbasi Dehkordi. (2019) The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip. Advanced Pharmaceutical Bulletin 9:3, pages 360-373.
Crossref
R. Pushpalatha, S. Selvamuthukumar & D. Kilimozhi. (2019) Cyclodextrin nanosponge based hydrogel for the transdermal co-delivery of curcumin and resveratrol: Development, optimization, in vitro and ex vivo evaluation. Journal of Drug Delivery Science and Technology 52, pages 55-64.
Crossref
Pal Patel, Nikita Meghani, Krupa Kansara & Ashutosh Kumar. (2019) Nanotherapeutics for the Treatment of Cancer and Arthritis. Current Drug Metabolism 20:6, pages 430-445.
Crossref
Manling Du, Yong Ouyang, Fansu Meng, Qianqian Ma, Hui Liu, Yong Zhuang, Mujuan Pang, Tiange Cai & Yu Cai. (2019) Nanotargeted agents: an emerging therapeutic strategy for breast cancer. Nanomedicine 14:13, pages 1771-1786.
Crossref
Dong-in Kim, Hyoryong Lee, Su-hyun Kwon, Hyunchul Choi & Sukho Park. (2019) Magnetic nano-particles retrievable biodegradable hydrogel microrobot. Sensors and Actuators B: Chemical 289, pages 65-77.
Crossref
Mohammad A. I. Al-Hatamleh, Suhana Ahmad, Jennifer C. Boer, JitKang Lim, Xin Chen, Magdalena Plebanski & Rohimah Mohamud. (2019) A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy. Journal of Oncology 2019, pages 1-13.
Crossref
Nouf N. Mahmoud, Dima A. Sabbah, Rana Abu-Dahab, Duaa Abuarqoub, Maha Abdallah, Ameerah (Hasan Ibrahim) & Enam A. Khalil. (2019) Cholesterol-coated gold nanorods as an efficient nano-carrier for chemotherapeutic delivery and potential treatment of breast cancer: in vitro studies using the MCF-7 cell line . RSC Advances 9:22, pages 12718-12731.
Crossref
Piumi Y. Liyanage, Sajini D. Hettiarachchi, Yiqun Zhou, Allal Ouhtit, Elif S. Seven, Cagri Y. Oztan, Emrah Celik & Roger M. Leblanc. (2019) Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1871:2, pages 419-433.
Crossref
Israel González-Méndez, José D. Solano, Pasquale Porcu, Andrea Ruiu, Yareli Rojas-Aguirre & Ernesto Rivera. (2019) Optimized synthesis, characterization and in vitro systematic evaluation of adamantane-doxorubicin prodrugs sensitive to pH in breast cancer cells. Journal of Molecular Structure 1177, pages 143-151.
Crossref
Yanan Liu, Meng Xu, Yingyu Zhao, Xu Chen, Xufeng Zhu, Chunfang Wei, Shuang Zhao, Jie Liu & Xiuying Qin. (2019) Flower-like gold nanoparticles for enhanced photothermal anticancer therapy by the delivery of pooled siRNA to inhibit heat shock stress response. Journal of Materials Chemistry B 7:4, pages 586-597.
Crossref
М. С. Истомина, Н. А. Печникова, Д. В. Королёв, Е. И. Почкаева, Д. С. Мазинг, М. М. Галагудза, В. А. Мошников & Е. В. Шляхто. (2018) Исследование коллоидных квантовых точек AginS2/ZnS в качестве флуоресцентных меток для тераностики: физические свойства, биораспределение и биосовместимость. Вестник Российского Государственного медицинского университета:6, pages 103-110.
Crossref
M.S. Istomina, N.A. Pechnikova, D.V. Korolev, E.I. Pochkayeva, D.S. Mazing, M.M. Galagudza, V.A. Moshnikov & E.V. Shlyakhto. (2018) ZAIS-based colloidal QDs as fluorescent labels for theranostics: physical properties, biodistribution and biocompatibility. Bulletin of Russian State Medical University:6, pages 94-101.
Crossref
Anu Hardenia, Neha Maheshwari, Shiv Shankar Hardenia, Sunil Kumar Dwivedi, Rahul Maheshwari & Rakesh K. Tekade. 2019. Basic Fundamentals of Drug Delivery. Basic Fundamentals of Drug Delivery 1 28 .
Diana Sousa, Débora Ferreira, Joana L. Rodrigues & Lígia R. Rodrigues. 2019. Applications of Targeted Nano Drugs and Delivery Systems. Applications of Targeted Nano Drugs and Delivery Systems 357 409 .
Shahnawaz Ahmad Baba, Ruchi Mutreja, Arun Beniwal, Shubham Jain, Ekta Yadav, Tamoghna Ghosh, Naveen K. Navani & Piyush Kumar. 2019. Aptamers. Aptamers 101 122 .
Lino Sánchez-Segura, Neftalí Ochoa-Alejo, Ramón Carriles & Laura E. Zavala-García. (2018) Development of bovine serum albumin–capsaicin nanoparticles for biotechnological applications. Applied Nanoscience 8:8, pages 1877-1886.
Crossref
Jodie M. Fleming, Susan T. Yeyeodu, Ashley McLaughlin, Darren Schuman & Darlene K. Taylor. (2018) In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix . ACS Chemical Biology 13:10, pages 2825-2840.
Crossref
Marta Kepinska, Rene Kizek & Halina Milnerowicz. (2018) Fullerene as a doxorubicin nanotransporter for targeted breast cancer therapy: Capillary electrophoresis analysis. ELECTROPHORESIS 39:18, pages 2370-2379.
Crossref
Santosh Kumar Singh, James W. LillardJr.Jr. & Rajesh Singh. (2018) Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. Cancer Letters 427, pages 49-62.
Crossref
M. P. Vinardell & M. Mitjans. 2018. Nanooncology. Nanooncology 341 364 .